An example is APRIL-CAR, which uses APRIL (a proliferation-inducing ligand) and is capable of binding with several receptors expressed on tumor cells—namely, BCMA and TACI (transmembrane activator and CAML interactor). The gene discussed is TNFRSF17; the disease is neoplasm.